Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Gliosarcoma 6 Glioblastoma 6 Head and Neck Neoplasms 5 Polycythemia Vera 4 Meningioma 4 Leukemia 4 Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Acute 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Central Nervous System Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Glioma 2 Congenital Abnormalities 2 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1

Interventions

Carboplatin 24 Paclitaxel 21 Gemcitabine 17 Cisplatin 16 pembrolizumab 12 Everolimus 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 7 Pemetrexed 7 Fluorouracil 7 130-nm albumin-bound paclitaxel 7 Radiotherapy 6 Nivolumab 6 Cetuximab 6 Panitumumab 5 Cyclophosphamide 5 Bevacizumab 5 Axitinib 5 trebananib 4 lenvatinib 4 Sunitinib 4 Sorafenib 4 Irinotecan 4 Gefitinib 4 volociximab 3 reolysin 3 padeliporfin 3 epothilone B 3 durvalumab 3 Octreotide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed

110 enrolled 14 charts

Carcinoma, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡